Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.

An ability of the Epstein-Barr virus latent membrane protein LMP1 to enhance the survival of infected B cells through upregulation of the bcl-2 oncogene was first suggested by experiments involving gene transfection and the selection of stable LMP1+ clones (S. Henderson, M. Rowe, C. Gregory, F. Wang...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Rowe, M, Peng-Pilon, M, Huen, D S, Hardy, R, Croom-Carter, D, Lundgren, E, Rickinson, A B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1994
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC236961/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7520093/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.68.9.5602-5612.1994
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!